BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26650342)

  • 1. Growth references for Japanese individuals with Noonan syndrome.
    Isojima T; Sakazume S; Hasegawa T; Ogata T; Nakanishi T; Nagai T; Yokoya S
    Pediatr Res; 2016 Apr; 79(4):543-8. PubMed ID: 26650342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth standards of patients with Noonan and Noonan-like syndromes with mutations in the RAS/MAPK pathway.
    Malaquias AC; Brasil AS; Pereira AC; Arnhold IJ; Mendonca BB; Bertola DR; Jorge AA
    Am J Med Genet A; 2012 Nov; 158A(11):2700-6. PubMed ID: 22887833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of auxological reference values for Japanese children with Noonan syndrome and comparison with growth in children with Turner syndrome.
    Isojima T; Sakazume S; Hasegawa T; Ogata T; Nakanishi T; Nagai T; Yokoya S
    Clin Pediatr Endocrinol; 2017; 26(3):153-164. PubMed ID: 28804206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noonan syndrome: clinical features, diagnosis, and management guidelines.
    Romano AA; Allanson JE; Dahlgren J; Gelb BD; Hall B; Pierpont ME; Roberts AE; Robinson W; Takemoto CM; Noonan JA
    Pediatrics; 2010 Oct; 126(4):746-59. PubMed ID: 20876176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A PTPN11 gene mutation (Y63C) causing Noonan syndrome is not associated with short stature in general population.
    Takahashi I; Utsunomiya M; Inoue K; Takahashi T; Nozaki J; Wada Y; Takada G; Koizumi A
    Tohoku J Exp Med; 2006 Mar; 208(3):255-9. PubMed ID: 16498234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Growth Characteristics of Patients with Noonan Syndrome: Results of Three Years of Growth Hormone Treatment: A Nationwide Multicenter Study.
    Şıklar Z; Genens M; Poyrazoğlu Ş; Baş F; Darendeliler F; Bundak R; Aycan Z; Savaş Erdeve Ş; Çetinkaya S; Güven A; Abalı S; Atay Z; Turan S; Kara C; Can Yılmaz G; Akyürek N; Abacı A; Çelmeli G; Sarı E; Bolu S; Korkmaz HA; Şimşek E; Çatlı G; Büyükinan M; Çayır A; Evliyaoğlu O; İşgüven P; Özgen T; Hatipoğlu N; Elhan AH; Berberoğlu M
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):305-12. PubMed ID: 27125300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Noonan syndrome: genetic and clinical update and treatment options].
    Carcavilla A; Suárez-Ortega L; Rodríguez Sánchez A; Gonzalez-Casado I; Ramón-Krauel M; Labarta JI; Quinteiro Gonzalez S; Riaño Galán I; Ezquieta Zubicaray B; López-Siguero JP
    An Pediatr (Engl Ed); 2020 Jul; 93(1):61.e1-61.e14. PubMed ID: 32493603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth response, near-adult height, and patterns of growth and puberty in patients with noonan syndrome treated with growth hormone.
    Romano AA; Dana K; Bakker B; Davis DA; Hunold JJ; Jacobs J; Lippe B
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2338-44. PubMed ID: 19401366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noonan syndrome in diverse populations.
    Kruszka P; Porras AR; Addissie YA; Moresco A; Medrano S; Mok GTK; Leung GKC; Tekendo-Ngongang C; Uwineza A; Thong MK; Muthukumarasamy P; Honey E; Ekure EN; Sokunbi OJ; Kalu N; Jones KL; Kaplan JD; Abdul-Rahman OA; Vincent LM; Love A; Belhassan K; Ouldim K; El Bouchikhi I; Shukla A; Girisha KM; Patil SJ; Sirisena ND; Dissanayake VHW; Paththinige CS; Mishra R; Klein-Zighelboim E; Gallardo Jugo BE; Chávez Pastor M; Abarca-Barriga HH; Skinner SA; Prijoles EJ; Badoe E; Gill AD; Shotelersuk V; Smpokou P; Kisling MS; Ferreira CR; Mutesa L; Megarbane A; Kline AD; Kimball A; Okello E; Lwabi P; Aliku T; Tenywa E; Boonchooduang N; Tanpaiboon P; Richieri-Costa A; Wonkam A; Chung BHY; Stevenson RE; Summar M; Mandal K; Phadke SR; Obregon MG; Linguraru MG; Muenke M
    Am J Med Genet A; 2017 Sep; 173(9):2323-2334. PubMed ID: 28748642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult height in Noonan syndrome.
    Noonan JA; Raaijmakers R; Hall BD
    Am J Med Genet A; 2003 Nov; 123A(1):68-71. PubMed ID: 14556249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of growth failure and other endocrine aspects in patients with Noonan syndrome across Europe: A sub-analysis of a European clinical practice survey.
    Edouard T; Zenker M; Östman-Smith I; Ortega Castelló E; Wolf CM; Burkitt-Wright E; Verloes A; García-Miñaúr S; Tartaglia M; Shaikh G; Lebl J
    Eur J Med Genet; 2022 Jan; 65(1):104404. PubMed ID: 34896604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Azygos anterior cerebral artery aneurysm in a patient with Noonan syndrome].
    Ryu B; Sato S; Yamaguchi K; Abe K; Ottomo D; Okada Y
    No Shinkei Geka; 2013 Sep; 41(9):773-7. PubMed ID: 24018784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of disease-specific growth charts in Turner syndrome and Noonan syndrome.
    Isojima T; Yokoya S
    Ann Pediatr Endocrinol Metab; 2017 Dec; 22(4):240-246. PubMed ID: 29301184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel heterozygous RIT1 mutation in a patient with Noonan syndrome, leukopenia, and transient myeloproliferation-a review of the literature.
    Nemcikova M; Vejvalkova S; Fencl F; Sukova M; Krepelova A
    Eur J Pediatr; 2016 Apr; 175(4):587-92. PubMed ID: 26518681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year response to growth hormone in children with Noonan syndrome and growth hormone deficiency.
    Zavras N; Meazza C; Pilotta A; Gertosio C; Pagani S; Tinelli C; Bozzola M
    Ital J Pediatr; 2015 Oct; 41():71. PubMed ID: 26444854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GH Therapy and first final height data in Noonan-like syndrome with loose anagen hair (Mazzanti syndrome).
    Mazzanti L; Tamburrino F; Scarano E; Perri A; Vestrucci B; Guidetti M; Rossi C; Tartaglia M
    Am J Med Genet A; 2013 Nov; 161A(11):2756-61. PubMed ID: 24124081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the genetic spectrum of Noonan syndrome.
    Noordam K
    Horm Res; 2007; 68 Suppl 5():24-7. PubMed ID: 18174700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal growth in noonan syndrome: genetic and endocrine features and optimal treatment.
    Padidela R; Camacho-Hübner C; Attie KM; Savage MO
    Horm Res; 2008; 70(3):129-36. PubMed ID: 18663312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable phenotypic expression in a large Noonan syndrome family segregating a novel SOS1 mutation.
    van Trier DC; Rinne T; Noordam K; Draaisma JM; van der Burgt I
    Am J Med Genet A; 2017 Nov; 173(11):2968-2972. PubMed ID: 28884940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GH Responsiveness in Children With Noonan Syndrome Compared to Turner Syndrome.
    Dahlgren J; Albertsson-Wikland K
    Front Endocrinol (Lausanne); 2021; 12():737893. PubMed ID: 34858328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.